International Myeloma Foundation

International Myeloma Foundation

The International Myeloma Foundation is an American non-profit organization serving patients with myeloma, a cancer of plasma cells in the bone marrow. The IMF also provides support and information for family members, caregivers of myeloma patients, physicians and nurses. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for International Myeloma Foundation, United States, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

58%


Total
Publications

153


Total Open
Publications

89


Total
Citations

9.9K


Open Access
Percentage

58%


Total
Publications

153


Total Open
Publications

89


Total
Citations

9.9K

Wikipedia

Website

download

Breakdown

16% 19% 23% 42%

Publisher Open

16%

Both

19%

Other Platform Open

23%

Closed

42%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

11

Hybrid 26%

14

No Guarantees 54%

29

Other Platform Open

Domain 55%

36

Preprint 42%

27

Institution 28%

18

Other Internet 22%

14

Public 3%

2

Other Platform Locations

Name

Platform Type

Publications

RePEc: Research Papers in Economics - RePEc
Preprint
37
PubMed Central
Domain
30
Europe PMC
Domain
24
Unknown Repository
Other Internet
12
Econstor
Domain
7
World Bank Group
Preprint
4
Semantic Scholar
Public
2
Massachusetts Institute of Technology - DSpace@MIT
Institution
2
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna
Institution
2
Würzburg University - Online Publication Service of Würzburg University
Institution
1
1 / 3

Data updated 25 January 2024

Share

Share

Share